5 (115) · $ 17.00 · In stock
Targeted Therapies for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
Scholarly Article or Book Chapter, Sacituzumab govitecan in metastatic triple-negative breast cancer, ID: bg257q66v
PDF) Triple-negative breast cancer: Investigating potential molecular therapeutic target
PDF) Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
Triple negative breast cancer (BCN248)
TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration l Fakultas Farmasi Militer
Immunogenic potential of medium-dose intermittent cyclophosphamide therapy in murine triple-negative breast cancer tumor lines 4T1 and E0771
Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?
PDF) Triple Negative Breast Cancer Prevalence in Indian Patients over a Decade: A Systematic Review
Medicina, Free Full-Text
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
Low-dose chemotherapy combined with NK cell-based immunotherapy as a treatment for triple negative breast cancer - IRep - Nottingham Trent University
PDF] Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
Adrian Pablo Hunis on LinkedIn: TRIPLE NEGATIVE BREAST CANCER (TNBC)